2001
DOI: 10.1378/chest.119.4.1001
|View full text |Cite
|
Sign up to set email alerts
|

Comparisons of Peak Diurnal Expiratory Flow Variation, Postbronchodilator FEV1 Responses, and Methacholine Inhalation Challenges in the Evaluation of Suspected Asthma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
53
0

Year Published

2003
2003
2017
2017

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 71 publications
(63 citation statements)
references
References 37 publications
4
53
0
Order By: Relevance
“…D'Urzo has correctly identified from our data [1] that bronchial challenge testing seems to be a more sensitive test to confirm asthma compared to pre-and post-bronchodilator spirometry. Our results were similar to those of GOLDSTEIN et al [2] who demonstrated that bronchial challenge testing with methacholine has far greater sensitivity to diagnose asthma compared with post-bronchodilator spirometry. Despite these findings, pre-and post-bronchodilator spirometry should probably be the first-line test to diagnose or confirm asthma for several reasons.…”
Section: From the Authorssupporting
confidence: 91%
“…D'Urzo has correctly identified from our data [1] that bronchial challenge testing seems to be a more sensitive test to confirm asthma compared to pre-and post-bronchodilator spirometry. Our results were similar to those of GOLDSTEIN et al [2] who demonstrated that bronchial challenge testing with methacholine has far greater sensitivity to diagnose asthma compared with post-bronchodilator spirometry. Despite these findings, pre-and post-bronchodilator spirometry should probably be the first-line test to diagnose or confirm asthma for several reasons.…”
Section: From the Authorssupporting
confidence: 91%
“…It is well known that bronchial hyperresponsiveness can occur in nonasthmatic patients, who might have been included in the present study, such as those with allergic rhinitis, those who have recently had a viral respiratory infection or smokers with normal lung function [15]. However, using a PC20 of f8 mg?mL -1 , the value used in the present study, GOLDSTEIN et al [14] demonstrated a specificity of 100% for the MCT.…”
Section: Discussionmentioning
confidence: 63%
“…The patients in whom asthma was excluded were followed for 6 months; however, it is possible for asthmatics to be symptom-free and show minimal airway inflammation and hyperresponsiveness for an unknown duration of time, especially if their asthma becomes manifest only with particular exposures. In a study of patients with undiagnosed respiratory symptoms possibly consistent with asthma who were followed for 6 months after a MCT, the sensitivity of the MCT, although far superior to either peak expiratory flow variability or postbronchodilator change in FEV1, was still only 86%, allowing for the possibility of false negative results [14]. It is also possible that asthma was falsely confirmed in some patients.…”
Section: Discussionmentioning
confidence: 99%
“…Excessive lung function variability, as assessed by peak expiratory flow (PEF), has been suggested to be a useful indicator of bronchial hyperresponsiveness for clinical or epidemiologic purposes (12)(13)(14)(15)(16). However, several studies have failed to identify an index of PEF variability that could be used to distinguish asthmatic persons from others (16,17), and PEF variability is not always significantly correlated with the slope of the dose-response curve of the methacholine challenge.…”
mentioning
confidence: 99%